Noteworthy new publications from the Congressional Research Service include the following.
Presidential Transition Act: Provisions and Funding, November 13, 2020
Federal Scientific Integrity Policies: A Primer, November 20, 2020
The Digital Divide: What Is It, Where Is It, and Federal Assistance Programs, November 17, 2020
Vaccine Safety in the United States: Overview and Considerations for COVID-19 Vaccines, November 4, 2020
Arms Sales in the Middle East: Trends and Analytical Perspectives for U.S. Policy, updated November 23, 2020
Federal Law Enforcement Use of Facial Recognition Technology, October 27, 2020
Searches and Seizures at the Border and the Fourth Amendment, November 12, 2020
Emerging Military Technologies: Background and Issues for Congress, updated November 10, 2020
While the U.S. has made significant advancements and remained a global leader in biotechnology over the past decade, the next four years will be critical in determining whether it can sustain that leadership.
As the efficacy of environmental laws has waned, so has their durability. What was once a broadly shared goal – protecting Americans from environmental harm – is now a political football, with rules that whipsaw back and forth depending on who’s in charge.
It takes the average person over 9 hours and costs $160 to file taxes each year. IRS Direct File meant it didn’t have to.
It’s paramount to balance both innovation capabilities and risk as we work towards ensuring that the U.S. bioeconomy is a priority area for both the Nation and for National Security.